Common Specialities
{{speciality.keyWord}}
Common Issues
{{issue.keyWord}}
Common Treatments
{{treatment.keyWord}}

Overview

Neutrophil Gelatinase Associated Lipocalin Test

Neutrophil Gelatinase Associated Lipocalin Test

also known as: lipocalin
Acute kidney injury (AKI) is a significant clinical problem in patients who are confined to hospitals. It touches upon a common which is a result of numerous factors and occurs in a diverse range of clinical settings, with varied clinical manifestations. This review focuses on recent studies examining the biological characteristics and the diagnostic and prognostic value of a novel biomarker – neutrophil gelatinase-associated lipocalin (NGAL) NGAL is one of the most intensively investigated novel renal biomarkers with promising data from animal experiments and clinical studies. NGAL was discovered using unbiased transcriptomic approaches and was identified as the gene with the earliest and highest rise of mRNA and protein concentration in renal tissue, urine and plasma following various renal insults.

1. Anti-NGAL Antibody Coated Micro plate one micro plate surfaced with polyclonal anti-human NGAL antibody. A foil zipper bag should be wrapped around it and kept dry.
2. HRP Conjugated Anti-NGAL Antibody One vial in a preserved protein matrix.
3. The contents must be diluted with 870 mL of demineralized water and mixed well.
4. ELISA HRP Substrate One bottle of tetramethylbenzidine (TMB) with hydrogen peroxide.
5. ELISA Stop Solution One bottle containing 12 mL of stop solution.
6. Human NGAL Standards Six vials containing recombinant human NGAL in a lyophilized bovine serum-based matrix with a non-azide preservative.
7. Human NGAL Controls Two vials containing human NGAL in a lyophilized bovine serum based matrix with a non azide preservative
8. Tracer Antibody Diluent One bottle ready-to-use buffer. It should be used only for tracer antibody dilution
9. Calprotectin/NGAL Extraction Buffer One bottle of 20-fold concentrate. Before use the contents must be diluted of demineralized water and mixed well.

A test for early diagnosis of acute kidney damage has been developed by the National Institute for Clinical Excellence (NICE) The NGAL Test is a laboratory test used to determine the level of a chemical in human urine and blood. It identifies the primary spot of the damage. (proximal tubule, distal tubule, interstitial or vascular); It brings to notice the duration since kidney failure (AKI, chronic kidney disease or ‘acute-on-chronic’ kidney injury) Identifying kidney aetiologies(ischemia, toxins, sepsis or a combination) It forecasts the future and stratifies risk Supervises the response to AKI interventions role in expediting the drug development process

1. It is recommended that all the measures, control and unexplained samples should be assayed in duplicate.
2. The light sensitive reagents should be saved in former amber bottles.
3. It is advised to store any unused antibody coated strips in the foil zipper bag.
4. Precise technique and use of properly calibrated pipetting devices becomes essential.
5. Variations or changes in incubation times or temperatures other than the ones stated may affect the results.
6. All reagents should be mixed gently and thoroughly prior to use

Specimen
random urine
Volume
10ml
Container
sterile specimen container
Type Gender Age-Group Value
Neutrophil Gelatinase Associated Lipocalin
UNISEX
All age groups
0.156-10ng/mL

Table of Content

What is Neutrophil Gelatinase Associated Lipocalin Test?
Preparation for Neutrophil Gelatinase Associated Lipocalin Test
Uses of Neutrophil Gelatinase Associated Lipocalin Test
Procedure for Neutrophil Gelatinase Associated Lipocalin Test
Specimen Requirements
Normal values for Neutrophil Gelatinase Associated Lipocalin Test
Lybrate Gaurantee
Lybrate Gaurantee